Novel insulin/GIP co‐producing cell lines provide unexpected insights into Gut K‐cell function in vivo
- 8 July 2002
- journal article
- research article
- Published by Wiley in Journal of Cellular Physiology
- Vol. 192 (3) , 339-350
- https://doi.org/10.1002/jcp.10139
Abstract
Enteroendocrine (EE) cells represent complex, rare, and diffusely-distributed intestinal epithelial cells making them difficult to study in vivo. A specific sub-population of EE cells called Gut K-cells produces and secretes glucose-dependent insulinotropic peptide (GIP), a hormone important for glucose homeostasis. The factors that regulate hormone production and secretion, as well as the timing of peptide release, are remarkably similar for K-cells and islet β-cells suggesting engineering insulin production by K-cells is a potential gene therapeutic strategy to treat diabetes. K-cell lines could be used to study the feasibility of this potential therapy and to understand Gut K-cell physiology in general. Heterogeneous STC-1 cells were transfected with a plasmid (pGIP/Neo) encoding neomycin phosphotransferase, driven by the GIP promoter-only cells in which the GIP promoter was active survived genetic selection. Additional clones expressing pGIP/Neo plus a GIP promoter/insulin transgene were isolated—only doubly transfected cells produced preproinsulin mRNA. Bioactive insulin was stored and then released following stimulation with arginine, peptones, and bombesin—physiological GIP secretagogues. Like K-cells in vivo, the GIP/insulin-producing cells express the critical glucose sensing enzyme, glucokinase. However, glucose did not regulate insulin or GIP secretion or mRNA levels. Conversely, glyceraldehyde and methyl-pyruvate were secretagogues, indicating cells depolarized in response to changes in intracellular metabolite levels. Potassium channel opening drugs and sulphonylureas had little effect on insulin secretion by K-cells. The K-cell lines also express relatively low levels of Kir 6.1, Kir 6.2, SUR1, and SUR2 suggesting secretion is independent of KATP channels. These results provided unexpected insights into K-cell physiology and our experimental strategy could be easily modified to isolate/characterize additional EE cell populations.Keywords
This publication has 52 references indexed in Scilit:
- Gastrin-releasing peptide is a novel mediator of proximal nutrient- induced proglucagon-derived peptide secretion from the distal gutEndocrinology, 1996
- Glucose-dependent insulinotropic peptide (GIP) gene expression in the rat salivary glandMolecular and Cellular Endocrinology, 1995
- A Tetraspan Membrane Glycoprotein Produced in the Human Intestinal Epithelium and Liver That Can Regulate Cell Density-dependent ProliferationJournal of Biological Chemistry, 1995
- Immunohistochemical studies indicate multiple enteroendocrine cell differentiation pathways in the mouse proximal small intestineDevelopmental Dynamics, 1994
- The family of subtilisin/kexin like pro-protein and pro-hormone convertases: Divergent or shared functionsBiochimie, 1994
- Regulation of intestinal proglucagon-derived peptide secretion by glucose-dependent insulinotropic peptide in a novel enteroendocrine loopEndocrinology, 1993
- Isolation and Characterization of the Gene Encoding Rat Glucose-Dependent Insulinotropic PeptideBiochemical and Biophysical Research Communications, 1993
- Molecular genetics of intestinal glucose transport.Journal of Clinical Investigation, 1991
- EVIDENCE FOR PREFERENTIAL STIMULATION OF GASTRIC INHIBITORY POLYPEPTIDE SECRETION IN THE RAT BY ACTIVELY TRANSPORTED CARBOHYDRATES AND THEIR ANALOGUESJournal of Endocrinology, 1980
- Phlorizin as a competitive inhibitor of the active transport of sugars by hamster small intestine, in vitroBiochimica et Biophysica Acta, 1962